Shizuoka, Japan

Motoshi Shoda

This inventor holds 2 USPTO granted patents. Top assignee: Toyo Jozo Kabushiki Kaisha. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Motoshi Shoda. Retrieved from https://idiyas.com/inventor/motoshi-shoda-q9tsgl41

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Motoshi Shoda: Innovator in Aldose Reductase Inhibitors

Introduction

Motoshi Shoda is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of aldose reductase inhibitors. His work is crucial for advancing therapies aimed at preventing diabetic complications.

Latest Patents

Motoshi Shoda holds 2 patents related to aldose reductase inhibitors. His latest patents include a compound that comprises a formula designed to exhibit superior aldose reductase inhibiting activity with high stability. This compound is beneficial for the prevention and therapy of diabetic complications. Another patent focuses on biphenyl-5,5'-bis-alkanoic acid derivatives, which also demonstrate effective aldose reductase inhibition and stability, further contributing to diabetes management.

Career Highlights

Motoshi Shoda is associated with Toyo Jozo Kabushiki Kaisha, where he continues to innovate in the field of pharmaceuticals. His research has led to advancements that are vital for improving patient outcomes in diabetes care.

Collaborations

Throughout his career, Motoshi Shoda has collaborated with notable colleagues, including Kouichi Kuno and Satoshi Yaginuma. These partnerships have fostered a collaborative environment that enhances the development of effective therapeutic solutions.

Conclusion

Motoshi Shoda's contributions to the field of aldose reductase inhibitors are significant and impactful. His innovative work continues to pave the way for advancements in diabetes treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…